Ikarian Capital, LLC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 54 filers reported holding FINCH THERAPEUTICS GROUP INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$93,359
-18.1%
237,5530.0%0.02%
-25.0%
Q4 2022$114,026
-71.3%
237,5530.0%0.03%
-64.6%
Q3 2022$397,000
-57.7%
237,553
-28.1%
0.08%
-53.8%
Q2 2022$938,000
-43.6%
330,5230.0%0.17%
-21.9%
Q1 2022$1,662,000
-47.2%
330,523
+4.7%
0.22%
-53.3%
Q4 2021$3,148,000
-23.3%
315,7320.0%0.47%
+62.3%
Q3 2021$4,106,000
-10.2%
315,732
-2.9%
0.29%
-21.9%
Q2 2021$4,573,000
+91.6%
325,000
+116.7%
0.37%
+362.5%
Q1 2021$2,387,000150,0000.08%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q1 2022
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders